METASTATIC COLORECTAL CANCER (MCRC)
Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat colorectal cancer: experimental combo enters human trials
Disease control Not yet recruitingThis study tests a new drug, LPM6690176, combined with standard chemotherapy and bevacizumab for people with a specific genetic form of metastatic colorectal cancer (RAS mutation). The trial has two parts: first, finding the safest dose in about 99 adults who have already tried o…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE1, PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
New drug cocktail aims to shrink Hard-to-Treat GI cancers
Disease control Not yet recruitingThis study tests a combination of two drugs (zanidatamab and tislelizumab) plus chemotherapy or radiation in people with HER2-positive gastrointestinal cancers, including rectal, stomach, and colorectal cancers. The goal is to see if this treatment can shrink tumors before surger…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated May 26, 2026 09:30 UTC